IONS - Biogen and Ionis drop ALS candidate after trial setback
2024-05-16 09:00:18 ET
More on Biogen, Ionis, etc.
- Ionis Pharmaceuticals, Inc. (IONS) Q1 2024 Earnings Call Transcript
- Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings
- Biogen: Don't Overthink This One
- Eisai projects major growth for Alzheimer's therapy Leqembi
- Biogen partner Eisai begins FDA submissions for injectable Alzheimer’s therapy